Follow
Andreas Hougaard Laustsen
Title
Cited by
Cited by
Year
Causes and consequences of snake venom variation
NR Casewell, TNW Jackson, AH Laustsen, K Sunagar
Trends in pharmacological sciences 41 (8), 570-581, 2020
2292020
Basics of antibody phage display technology
L Ledsgaard, M Kilstrup, A Karatt-Vellatt, J McCafferty, AH Laustsen
Toxins 10 (6), 236, 2018
2292018
Bee updated: current knowledge on bee venom and bee envenoming therapy
MB Pucca, FA Cerni, IS Oliveira, TP Jenkins, L Argemí, CV Sørensen, ...
Frontiers in immunology 10, 478911, 2019
1542019
Pros and cons of different therapeutic antibody formats for recombinant antivenom development
AH Laustsen, JM Gutiérrez, C Knudsen, KH Johansen, ...
Toxicon 146, 151-175, 2018
1542018
Unveiling the nature of black mamba (Dendroaspis polylepis) venom through venomics and antivenom immunoprofiling: Identification of key toxin targets for antivenom development
AH Laustsen, B Lomonte, B Lohse, J Fernández, JM Gutiérrez
Journal of proteomics 119, 126-142, 2015
1352015
From fangs to pharmacology: the future of snakebite envenoming therapy
A H Laustsen, M Engmark, C Milbo, J Johannesen, B Lomonte, ...
Current Pharmaceutical Design 22 (34), 5270-5293, 2016
1282016
History of envenoming therapy and current perspectives
MB Pucca, FA Cerni, R Janke, E Bermúdez-Méndez, L Ledsgaard, ...
Frontiers in immunology 10, 1598, 2019
1052019
In vivo neutralization of dendrotoxin-mediated neurotoxicity of black mamba venom by oligoclonal human IgG antibodies
AH Laustsen, A Karatt-Vellatt, EW Masters, AS Arias, U Pus, C Knudsen, ...
Nature communications 9 (1), 3928, 2018
1052018
Scorpion venom: detriments and benefits
S Ahmadi, JM Knerr, L Argemi, KCF Bordon, MB Pucca, FA Cerni, ...
Biomedicines 8 (5), 118, 2020
992020
Exploring the venom of the forest cobra snake: Toxicovenomics and antivenom profiling of Naja melanoleuca
LP Lauridsen, AH Laustsen, B Lomonte, JM Gutiérrez
Journal of proteomics 150, 98-108, 2017
972017
Recombinant snakebite antivenoms: A cost-competitive solution to a neglected tropical disease?
AH Laustsen, KH Johansen, M Engmark, MR Andersen
PLOS Neglected Tropical Diseases 11 (2), e0005361, 2017
922017
Selecting key toxins for focused development of elapid snake antivenoms and inhibitors guided by a Toxicity Score
AH Laustsen, B Lohse, B Lomonte, M Engmark, JM Gutiérrez
Toxicon 104, 43-45, 2015
922015
Animal immunization, in vitro display technologies, and machine learning for antibody discovery
AH Laustsen, V Greiff, A Karatt-Vellatt, S Muyldermans, TP Jenkins
Trends in Biotechnology 39 (12), 1263-1273, 2021
882021
Toxicovenomics and antivenom profiling of the Eastern green mamba snake (Dendroaspis angusticeps)
LP Lauridsen, AH Laustsen, B Lomonte, JM Gutiérrez
Journal of proteomics 136, 248-261, 2016
842016
Snake venomics of monocled cobra (Naja kaouthia) and investigation of human IgG response against venom toxins
AH Laustsen, JM Gutiérrez, B Lohse, AR Rasmussen, J Fernández, ...
Toxicon 99, 23-35, 2015
812015
Innovative immunization strategies for antivenom development
E Bermúdez-Méndez, A Fuglsang-Madsen, S Føns, B Lomonte, ...
Toxins 10 (11), 452, 2018
802018
Biosynthetic oligoclonal antivenom (BOA) for snakebite and next-generation treatments for snakebite victims
RM Kini, SS Sidhu, AH Laustsen
Toxins 10 (12), 534, 2018
792018
Biotechnological trends in spider and scorpion antivenom development
AH Laustsen, M Solà, EC Jappe, S Oscoz, LP Lauridsen, M Engmark
Toxins 8 (8), 226, 2016
782016
Advances in antibody phage display technology
L Ledsgaard, A Ljungars, C Rimbault, CV Sørensen, T Tulika, J Wade, ...
Drug Discovery Today 27 (8), 2151-2169, 2022
732022
Recent advances in next generation snakebite antivenoms
C Knudsen, AH Laustsen
Tropical Medicine and Infectious Disease 3 (2), 42, 2018
692018
The system can't perform the operation now. Try again later.
Articles 1–20